Acceleration of periosteal bone formation by human basic fibroblast growth factor containing a collagen-binding domain from Clostridium histolyticum collagenase

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 6, 2014, Pages 1737-1743

  Uchida, Kentaro ^a   Matsushita, Osamu ^b   Naruse, Kouji ^a   Mima, Takehiko ^b   Nishi, Nozomu ^c   Hattori, Shunji ^d   Ogura, Takayuki ^d   Inoue, Gen ^a   Tanaka, Keisuke ^d   Takaso, Masashi ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d NIPPI RESEARCH INSTITUTE OF BIOMATRIX   (Japan)

Author keywords

basic fibroblast growth factor; bone repair; bone tissue engineering; collagen; collagen binding domain

Indexed keywords

BIOACTIVITY; CELL CULTURE; CLOSTRIDIUM; COLLAGEN; TISSUE ENGINEERING;

BASIC FIBROBLAST GROWTH FACTOR; BONE REPAIR; BONE TISSUE ENGINEERING; CLINICAL SETTINGS; COLLAGEN BINDING DOMAIN; DEMINERALIZED BONE MATRIX; PROTEIN CONCENTRATIONS; THERAPEUTIC EFFECTS;

BONE;

CLOSTRIDIOPEPTIDASE A; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; HYBRID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; BIOLOGICAL ACTIVITY; BONE MASS; BONE MATRIX; BONE MINERAL; BONE REMODELING; CELL PROLIFERATION; CONTROLLED STUDY; IN VITRO STUDY; LIMIT OF DETECTION; MESENCHYME CELL; MOUSE; NONHUMAN; OSSIFICATION; PERIOSTEUM; RAT; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; CHEMISTRY; CLOSTRIDIUM HISTOLYTICUM; DRUG EFFECTS; ENZYMOLOGY; HUMAN; MALE; METABOLISM; PROTEIN TERTIARY STRUCTURE; WISTAR RAT; WOUND HEALING;

ANIMALS; CELLS, CULTURED; CLOSTRIDIUM HISTOLYTICUM; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MICROBIAL COLLAGENASE; OSTEOGENESIS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; WOUND HEALING;

EID: 84897065658     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34841     Document Type: Article

References (41)

1. Ueno M, Urabe K, Naruse K, Uchida K, Minehara H, Yamamoto T, Steck R, Gregory L, Wullschleger ME, Schuetz MA, Itoman M,. Influence of internal fixator stiffness on murine fracture healing: Two types of fracture healing lead to two distinct cellular events and FGF-2 expressions. Exp Anim 2011; 60: 79-87.
2. Ueno M, Uchida K, Takaso M, Minehara H, Suto K, Takahira N, Steck R, Schuetz MA, Itoman M,. Distribution of bone marrow-derived cells in the fracture callus during plate fixation in a green fluorescent protein-chimeric mouse model. Exp Anim 2011; 60: 455-462.
3. Nakamura S, Nambu M, Ishizuka T, Hattori H, Kanatani Y, Takase B, Kishimoto S, Amano Y, Aoki H, Kiyosawa T, Ishihara M, Maehara T,. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization. J Biomed Mater Res A 2008; 85: 619-627.
4. Varkey M, Kucharski C, Haque T, Sebald W, Uludag H,. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin Orthop Relat Res 2006; 443: 113-123.
5. Canalis E, Centrella M, McCarthy T,. Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 1988; 81: 1572-1577.
6. Khan SN, Bostrom MP, Lane JM,. Bone growth factors. Orthop Clin North Am 2000; 31: 375-388.
7. Kato T, Kawaguchi H, Hanada K, Aoyama I, Hiyama Y, Nakamura T, Kuzutani K, Tamura M, Kurokawa T, Nakamura K,. Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 1998; 16: 654-659.
8. Kawaguchi H, Nakamura K, Tabata Y, Ikada Y, Aoyama I, Anzai J, Nakamura T, Hiyama Y, Tamura M,. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 2001; 86: 875-880.
9. Kawaguchi H, Kurokawa T, Hanada K, Hiyama Y, Tamura M, Ogata E, Matsumoto T,. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 1994; 135: 774-781.
10. Nakamura K, Kawaguchi H, Aoyama I, Hanada K, Hiyama Y, Awa T, Tamura M, Kurokawa T,. Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J Orthop Res 1997; 15: 307-313.
11. Radomsky ML, Aufdemorte TB, Swain LD, Fox WC, Spiro RC, Poser JW,. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res 1999; 17: 607-614.
12. Tabata Y, Yamada K, Hong L, Miyamoto S, Hashimoto N, Ikada Y,. Skull bone regeneration in primates in response to basic fibroblast growth factor. J Neurosurg 1999; 91: 851-856.
13. Kawaguchi H, Jingushi S, Izumi T, Fukunaga M, Matsushita T, Nakamura T, Mizuno K, Nakamura T, Nakamura K,. Local application of recombinant human fibroblast growth factor-2 on bone repair: A dose-escalation prospective trial on patients with osteotomy. J Orthop Res 2007; 25: 480-487.
14. Kawaguchi H, Oka H, Jingushi S, Izumi T, Fukunaga M, Sato K, Matsushita T, Nakamura K,. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial. J Bone Miner Res 2010; 25: 2735-2743.
15. Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski R,. Therapeutic interventions for enhancing collateral development by administration of growth factors: Basic principles, early results and potential hazards. Cardiovasc Res 2001; 49: 532-542.
16. Unger EF, Goncalves L, Epstein SE, Chew EY, Trapnell CB, Cannon RO, III, Quyyumi AA,. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol 2000; 85: 1414-1419.
17. Kamo K, Miyakoshi N, Kasukawa Y, Sasaki H, Shimada Y,. Effects of single and cyclical local injections of basic fibroblast growth factor on cancellous bone defects in rabbits. J Orthop Sci 2009; 14: 811-819.
18. Lu M, Rabie AB,. The effect of demineralized intramembranous bone matrix and basic fibroblast growth factor on the healing of allogeneic intramembranous bone grafts in the rabbit. Arch Oral Biol 2002; 47: 831-841.
19. Omata K, Matsuno T, Asano K, Hashimoto Y, Tabata Y, Satoh T,. Enhanced bone regeneration by gelatin-beta-tricalcium phosphate composites enabling controlled release of bFGF. J Tissue Eng Regen Med 2012, DOI: 10.1002/term.1553.
20. Zellin G, Linde A,. Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo. Bone 2000; 26: 161-168.
21. Zou GK, Song YL, Zhou W, Yu M, Liang LH, Sun DC, Li DH, Deng ZX, Zhu WZ,. Effects of local delivery of bFGF from PLGA microspheres on osseointegration around implants in diabetic rats. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: 284-289.
22. Andrades JA, Wu LT, Hall FL, Nimni ME, Becerra J,. Engineering, expression, and renaturation of a collagen-targeted human bFGF fusion protein. Growth Factors 2001; 18: 261-275.
23. Chen B, Lin H, Wang J, Zhao Y, Wang B, Zhao W, Sun W, Dai J,. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 2007; 28: 1027-1035.
24. Chen B, Lin H, Zhao Y, Wang B, Zhao Y, Liu Y, Liu Z, Dai J,. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. J Biomed Mater Res A 2007; 80: 428-434.
25. Kitajima T, Terai H, Ito Y,. A fusion protein of hepatocyte growth factor for immobilization to collagen. Biomaterials 2007; 28: 1989-1997.
26. Shi C, Chen W, Zhao Y, Chen B, Xiao Z, Wei Z, Hou X, Tang J, Wang Z, Dai J,. Regeneration of full-thickness abdominal wall defects in rats using collagen scaffolds loaded with collagen-binding basic fibroblast growth factor. Biomaterials 2011; 32: 753-759.
27. Visser R, Arrabal PM, Becerra J, Rinas U, Cifuentes M,. The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo. Biomaterials 2009; 30: 2032-2037.
28. Nishi N, Matsushita O, Yuube K, Miyanaka H, Okabe A, Wada F,. Collagen-binding growth factors: Production and characterization of functional fusion proteins having a collagen-binding domain. Proc Natl Acad Sci USA 1998; 95: 7018-7023.
29. Toyoshima T, Matsushita O, Minami J, Nishi N, Okabe A, Itano T,. Collagen-binding domain of a Clostridium histolyticum collagenase exhibits a broad substrate spectrum both in vitro and in vivo. Connect Tissue Res 2001; 42: 281-290.
30. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I,. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007; 327: 449-462.
31. Uchida K, Urabe K, Naruse K, Ujihira M, Mabuchi K, Itoman M,. Comparison of the cytokine-induced migratory response between primary and subcultured populations of rat mesenchymal bone marrow cells. J Orthop Sci 2007; 12: 484-492.
32. Onuma K, Urabe K, Naruse K, Uchida K, Itoman M,. Allogenic serum improves cold preservation of osteochondral allografts. Clin Orthop Relat Res 2012; 470: 2905-2914.
33. Hall FL, Kaiser A, Liu L, Chen ZH, Hu J, Nimni ME, Beart RW, Jr, Gordon EM,. Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: Efficacy in an animal model of experimental colitis. Int J Mol Med 2000; 6: 635-643.
34. de Souza SJ, Brentani R,. Collagen binding site in collagenase can be determined using the concept of sense-antisense peptide interactions. J Biol Chem 1992; 267: 13763-13767.
35. Ishikawa T, Eguchi M, Wada M, Iwami Y, Tono K, Iwaguro H, Masuda H, Tamaki T, Asahara T,. Establishment of a functionally active collagen-binding vascular endothelial growth factor fusion protein in situ. Arterioscler Thromb Vasc Biol 2006; 26: 1998-2004.
36. Chen W, Shi C, Yi S, Chen B, Zhang W, Fang Z, Wei Z, Jiang S, Sun X, Hou X, Xiao Z, Ye G, Dai J,. Bladder regeneration by collagen scaffolds with collagen binding human basic fibroblast growth factor. J Urol 2010; 183: 2432-2439.
37. Peel SA, Hu ZM, Clokie CM,. In search of the ideal bone morphogenetic protein delivery system: In vitro studies on demineralized bone matrix, purified, and recombinant bone morphogenetic protein. J Craniofac Surg 2003; 14: 284-291.
38. Tuli SM, Singh AD,. The osteoninductive property of decalcified bone matrix. An experimental study. J Bone Joint Surg Br 1978; 60: 116-123.
39. Wittbjer J, Palmer B, Rohlin M, Thorngren KG,. Osteogenetic activity in composite grafts of demineralized compact bone and marrow. Clin Orthop Relat Res 1983; 229-238.
40. Alam S, Ueki K, Marukawa K, Ohara T, Hase T, Takazakura D, Nakagawa K,. Expression of bone morphogenetic protein 2 and fibroblast growth factor 2 during bone regeneration using different implant materials as an onlay bone graft in rabbit mandibles. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 16-26.
41. Maegawa N, Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H,. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med 2007; 1: 306-313.